MDedge Hematology & Oncology
@MDedgeHemOnc
Followers
8K
Following
289
Media
4K
Statuses
11K
MDedge Hematology & Oncology provides the most important and up to date information and news for oncologists. Now part of the Medscape Professional Network.
Rockville, MD, Parsippany, NJ
Joined June 2009
Antibody-drug conjugate changes standard of care for platinum-resistant ovarian cancer https://t.co/JxQr1j7tmQ
0
0
0
#ASCO23 Many patients with locally advanced rectal cancer who do not have high-risk disease can skip radiotherapy to the pelvic area, and instead be treated with chemotherapy alone and then surgery, say researchers reporting results from the PROSPECT trial https://t.co/dBzlnv0Wmh
0
1
0
New results in the treatment of advanced ovarian cancer have been welcomed by an expert not involved in the trial, even though the study showed only an improvement in PFS, not yet overall survival. https://t.co/pW3J6QF8ug
0
0
1
Ribociclib forestalls recurrence also in early breast cancer #ASCO23
https://t.co/k4wT6xtIFm
0
1
0
A telephone-based weight loss intervention resulted in clinically meaningful weight loss in patients with breast cancer who were overweight and obese. #ASCO23
https://t.co/1yKwzRVkNJ
0
1
0
Racial disparities in cancer care have been reduced by Medicaid expansion, suggest new nationwide data. #ASCO23
https://t.co/l3uonbVpSP
0
1
0
Cross-border U.S.-Mexican collaboration drives up ALL survival #ASCO23
https://t.co/97sNvtaUJH
0
1
0
🆕 meta-analysis of 25 studies dating back to 1948 provides more evidence linking ovarian suppression/ablation in premenopausal women to less recurrence and more survival in the long term after breast cancer. #ASCO23
https://t.co/malsdn9bxj
0
1
0
Surgical de-escalation passes clinical test in low-risk #cervicalcancer #ASCO23
https://t.co/c7GCLandHW
0
1
0
People exposed to high levels of PFOS – a widely used synthetic chemical – run an increased risk of #HCC, researchers say. https://t.co/4Lgh3j7Shp
0
0
2
A live birth after the diagnosis of BC does not have a negative impact on a woman’s OS. https://t.co/mpEJrPkWAP
0
0
1
Select chemopreventive agents may effectively decrease the incidence of precursor colorectal adenomas, thus lowering the future burden of CRC. https://t.co/rYZYAHmbp1
0
0
0
Adding high-dose vitamin C to first-line chemotherapy does not significantly improve PFS in patients with mCRC but may benefit patients with RAS mutation. https://t.co/TVwkEllZSL
0
0
4
The real competition in medicine is not between companies. Rather it's us against disease. https://t.co/BiWSfglAir
#Changemakers via @drjohnwhyte
0
0
1
#ICYMI THE NEW GASTROENTEROLOGIST's overview of therapeutic management of #NAFLD
https://t.co/8g0i6PJLq4
0
0
1